AAM
AGN

Advisors Asset Management’s Allergan Inc AGN Stock Holding History

Advisors Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-36,433
Closed -$7.75M – 1872
2014
Q4 		$7.75M Sell
36,433
-733
-2% -$146K 0.1% 248
2014
Q3 		$6.62M Buy
37,166
+1,174
+3% +$195K 0.09% 281
2014
Q2 		$6.09M Buy
35,992
+9,725
+37% +$1.51M 0.08% 286
2014
Q1 		$3.26M Buy
26,267
+9,855
+60% +$1.2M 0.05% 423
2013
Q4 		$1.82M Buy
16,412
+2,770
+20% +$265K 0.03% 530
2013
Q3 		$1.23M Sell
13,642
-5,022
-27% -$451K 0.02% 618
2013
Q2 		$1.57M Buy
+18,664
New +$1.94M 0.03% 520

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Advisors Asset Management's AGN Position: Q1 2015 in Review

Advisors Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 36,433 shares — an estimated $7.75M sold.

Advisors Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $7.75M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Advisors Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Advisors Asset Management sold 36,433 Allergan Inc shares in Q1 2015, an estimated $7.75M.
  • Advisors Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Advisors Asset Management's Allergan Inc position peaked at $7.75M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Advisors Asset Management's 13F filing for Q1 2015, filed 13 May 2015.